More Aggressive Cancer Behaviour in Thyroid Cancer Patients in the Post-COVID-19 Pandemic Era: A Retrospective Study

References

• Coronavirus disease (COVID-19) pandemic [homepage on the Internet]. Geneva: World Health Organization; 2021. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed September 17, 2021.
   Google Scholar
• Klompas M, Morris CA, Sinclair J, Pearson M, Shenoy ES. Universal masking in hospitals in the Covid-19 era. N Engl J Med. 2020;382(21):e63. doi:10.1056/NEJMp2006372
   PubMed Web of Science ®Google Scholar
• Lee JK, Jeong HW. Wearing face masks regardless of symptoms is crucial for preventing the spread of COVID-19 in hospitals. Infect Control Hosp Epidemiol. 2020;42(1):115–116. doi:10.1017/ice.2020.202
   PubMed Web of Science ®Google Scholar
• Bhatla N, Singhal S. The COVID-19 pandemic and implications for gynaecologic cancer care. Indian J Gynecol Oncol. 2020;18(2):48. doi:10.1007/s40944-020-00395-7
   PubMed Web of Science ®Google Scholar
• Mlcochova P, Collier D, Ritchie A, et al. Combined point-of-care nucleic acid and antibody testing for SARS-CoV-2 following emergence of D614G spike variant. Cell Rep Med. 2020;1(6):100099. doi:10.1016/j.xcrm.2020.100099
   PubMedGoogle Scholar
• Frey MK, Fowlkes RK, Badiner NM, et al. Gynecologic oncology care during the COVID-19 pandemic at three affiliated New York City hospitals. Gynecol Oncol. 2020;159(2):470–475. doi:10.1016/j.ygyno.2020.09.005
   PubMed Web of Science ®Google Scholar
• Papautsky EL, Hamlish T. Patient-reported treatment delays in breast cancer care during the COVID-19 pandemic. Breast Cancer Res Treat. 2020;184(1):249–254. doi:10.1007/s10549-020-05828-7
   PubMed Web of Science ®Google Scholar
• Sha Z, Chang K, Mi J, et al. The impact of the COVID-19 pandemic on lung cancer patients. Ann Palliat Med. 2020;9(5):3373–3378. doi:10.21037/apm-20-1662
   PubMed Web of Science ®Google Scholar
• Li J, Santa-Maria CA, Feng H, et al. Patient-reported outcomes of patients with breast cancer during the COVID-19 outbreak in the epicenter of China: a cross-sectional survey study. Clin Breast Cancer. 2020;20(5):E651–E662. doi:10.1016/j.clbc.2020.06.003
   PubMed Web of Science ®Google Scholar
• Casco NC, Carmona MJ, Soto AJ. Therapeutic and surgical indications for patients with penile cancer in the COVID-19 era. Int Braz J Urol. 2020;46(suppl.1):86–92. doi:10.1590/s1677-5538.ibju.2020.s110
   PubMedGoogle Scholar
• Shipe ME, Haddad DN, Deppen SA, Kozower BD, Grogan EL. Modeling the impact of delaying the diagnosis of non-small cell lung cancer during COVID-19. Ann Thorac Surg. 2020;19:248–254.
   Google Scholar
• Lung Cancer Study Group CTSCMA, Chinese Respiratory Oncology C. Expert recommendations on the management of patients with advanced non-small cell lung cancer during epidemic of coronavirus disease 2019 (Trial version). Zhonghua Jie He He Hu Xi Za Zhi. 2020;43(4):297–301.
   PubMedGoogle Scholar
• Brissot E, Labopin M, Baron F, et al. Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant. 2021;56(3):532–535. doi:10.1038/s41409-020-0970-x
   PubMed Web of Science ®Google Scholar
• Conforti C, Giuffrida R, Di Meo N, Zalaudek I. Management of advanced melanoma in the COVID-19 era. Dermatol Ther. 2020;33(4):e13444. doi:10.1111/dth.13444
   PubMed Web of Science ®Google Scholar
• Raghavan D, Tan AR, Story ES, et al. Management changes for patients with endocrine-related cancers in the COVID-19 pandemic. Endocr Relat Cancer. 2020;27(9):E357–E374. doi:10.1530/ERC-20-0229
   Web of Science ®Google Scholar
• Assi T, Ibrahim N, Abboud RMK, et al. The management of patients with metastatic prostate cancer during the COVID-19 pandemic. Fut Oncol. 2020;16(20):1455–1462. doi:10.2217/fon-2020-0361
   PubMed Web of Science ®Google Scholar
• Salazar-Vega J, Ortiz-Prado E, Solis-Pazmino P, et al. Thyroid cancer in Ecuador, a 16 years population-based analysis (2001–2016). BMC Cancer. 2019;19(1):294. doi:10.1186/s12885-019-5485-8
   PubMed Web of Science ®Google Scholar
• Hoang JK, Nguyen XV, Davies L. Overdiagnosis of thyroid cancer: answers to five key questions. Acad Radiol. 2015;22(8):1024–1029. doi:10.1016/j.acra.2015.01.019
   PubMed Web of Science ®Google Scholar
• O’Grady TJ, Gates MA, Boscoe FP. Thyroid cancer incidence attributable to overdiagnosis in the United States 1981–2011. Int J Cancer. 2015;137(11):2664–2673. doi:10.1002/ijc.29634
   PubMed Web of Science ®Google Scholar
• Davies L, Hoang JK. Thyroid cancer in the USA: current trends and outstanding questions. Lancet Diabetes Endocrinol. 2021;9(1):11–12. doi:10.1016/S2213-8587(20)30372-7
   PubMed Web of Science ®Google Scholar
• Morris LGT, Myssiorek D. Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis. Am J Surg. 2010;200(4):454–461. doi:10.1016/j.amjsurg.2009.11.008
   PubMed Web of Science ®Google Scholar
• Bresner L, Banach R, Rodin G, Thabane L, Ezzat S, Sawka AM. Cancer-related worry in Canadian thyroid cancer survivors. J Clin Endocrinol Metab. 2015;100(3):977–985. doi:10.1210/jc.2014-3169
   PubMed Web of Science ®Google Scholar
• Andersen JH, Jensen JC. Modern health worries and visits to the general practitioner in a general population sample: an 18 month follow-up study. J Psychosom Res. 2012;73(4):264–267. doi:10.1016/j.jpsychores.2012.07.007
   PubMed Web of Science ®Google Scholar
• Fenton JJ, Magnan EM, Jerant A, Kravitz RL, Franks P. Patient characteristics associated with making requests during primary care visits. J Am Board Fam Med. 2019;32(2):201–208. doi:10.3122/jabfm.2019.02.180218
   PubMed Web of Science ®Google Scholar
• Campenni A, Barbaro D, Guzzo M, Capoccetti F, Giovanella L. Personalized management of differentiated thyroid cancer in real life - practical guidance from a multidisciplinary panel of experts. Endocrine. 2020;70(2):280–291. doi:10.1007/s12020-020-02418-x
   PubMed Web of Science ®Google Scholar
• Health Commission of Hubei Province. In extraordinary times, necessary diagnosis and treatment are guaranteed, Wuhan medical institutions are in action [homepage on the Internet]. Wuhan: Health Commission of Hubei Province; 2021. Available from: http://wjw.hubei.gov.cn/bmdt/ztzl/fkxxgzbdgrfyyq/fkdt/202002/t20200214_2027302.shtml. Accessed February 14, 2021.
   Google Scholar
• Tessler FN, Middleton WD, Grant EG, et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): white paper of the ACR TI-RADS committee. J Am Coll Radiol. 2017;14(5):587–595. doi:10.1016/j.jacr.2017.01.046
   PubMed Web of Science ®Google Scholar
• Tsang VHM, Gild M, Glover A, Clifton-Bligh R, Robinson BG. Thyroid cancer in the age of COVID-19. Endocr Relat Cancer. 2020;27(11):R407–R416. doi:10.1530/ERC-20-0279
   PubMed Web of Science ®Google Scholar
• Krishan K, Kanchan T. Lockdown is an effective ‘vaccine’ against COVID-19: a message from India. J Infect Dev Ctries. 2020;14(6):545–546. doi:10.3855/jidc.12931
   PubMed Web of Science ®Google Scholar
• Siqueira CA, de Freitas YNL, Cancela MD, Carvalho M, Oliveras-Fabregas A, de Souza DLB. The effect of lockdown on the outcomes of COVID-19 in Spain: an ecological study. PLoS One. 2020;15(7):e0236779. doi:10.1371/journal.pone.0236779
   PubMed Web of Science ®Google Scholar
• Qian Y, Hanser A. How did Wuhan residents cope with a 76-day lockdown? Chin Sociol Rev. 2020;53(1):55–86. doi:10.1080/21620555.2020.1820319
   Web of Science ®Google Scholar
• Smulever A, Abelleira E, Bueno F, Pitoia F. Thyroid cancer in the Era of COVID-19. Endocrine. 2020;70(1):1–5. doi:10.1007/s12020-020-02439-6
   PubMed Web of Science ®Google Scholar
• Vrachimis A, Iakovou I, Giannoula E, Giovanella L. Endocrinology in the time of COVID-19 management of thyroid nodules and cancer. Eur J Endocrinol. 2020;183(1):G41–G48. doi:10.1530/EJE-20-0269
   PubMed Web of Science ®Google Scholar
• Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer The American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.
   PubMed Web of Science ®Google Scholar
• Joseph KR, Edirimanne S, Eslick GD. Multifocality as a prognostic factor in thyroid cancer: a meta-analysis. Int J Surg. 2018;50:121–125. doi:10.1016/j.ijsu.2017.12.035
   PubMed Web of Science ®Google Scholar
• Park YM, Lee DY, Oh KH, et al. Clinical implications of pathologic factors after thyroid lobectomy in patients with papillary thyroid carcinoma. Oral Oncol. 2017;75:1–5. doi:10.1016/j.oraloncology.2017.10.012
   PubMed Web of Science ®Google Scholar
• Olson E, Wintheiser G, Wolfe KM, Droessler J, Silberstein PT. Epidemiology of thyroid cancer: a review of the national cancer database, 2000–2013. Cureus. 2019;11(2):e4127.
   PubMed Web of Science ®Google Scholar
• Falcone R, Grani G, Ramundo V, et al. Cancer care during COVID-19 era: the quality of life of patients with thyroid malignancies. Front Oncol. 2020;10:1128. doi:10.3389/fonc.2020.01128
   PubMed Web of Science ®Google Scholar
• Akula SM, Abrams SL, Steelman LS, et al. Cancer therapy and treatments during COVID-19 era. Adv Biol Regul. 2020;77:100739. doi:10.1016/j.jbior.2020.100739
   PubMedGoogle Scholar
• Kim TY, Shong YK. Active surveillance of papillary thyroid microcarcinoma: a mini-review from Korea. Endocrinol Metab. 2017;32(4):399–406. doi:10.3803/EnM.2017.32.4.399
   Web of Science ®Google Scholar
• Tuttle RM, Ahuja S, Avram AM, et al. Controversies, consensus, and collaboration in the use of I-131 therapy in differentiated thyroid cancer: a joint statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association. Thyroid. 2019;29(4):461–470.
   PubMed Web of Science ®Google Scholar
• Shaha AR. Thyroid surgery during COVID-19 pandemic: principles and philosophies. Head Neck. 2020;42(6):1322–1324. doi:10.1002/hed.26198
   PubMed Web of Science ®Google Scholar
• Campenni A, Giovanella L, Siracusa M, et al. Is malignant nodule topography an additional risk factor for metastatic disease in low-risk differentiated thyroid cancer? Thyroid. 2014;24(11):1607–1611. doi:10.1089/thy.2014.0217
   PubMed Web of Science ®Google Scholar
• Campenni A, Ruggeri RM, Siracusa M, et al. Isthmus topography is a risk factor for persistent disease in patients with differentiated thyroid cancer. Eur J Endocrinol. 2021;185(3):397–404. doi:10.1530/EJE-21-0328
   PubMed Web of Science ®Google Scholar